Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice

Journal of Neuroscience

Volumn 30, Issue 1, 2010, Pages 183-193

  Ohlmann, Andreas ^a   Seitz, Roswitha ^a   Braunger, Barbara ^a   Seitz, David ^a   Bösl, Michael R ^b   Tamm, Ernst R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; DICKKOPF 1 PROTEIN; NORRIN; OXYGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BRAIN HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINOPATHY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EYE PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MICROCIRCULATION; NERVE TISSUE PROTEINS; OXYGEN; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 74849101559     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3210-09.2010     Document Type: Article

References (40)

1. Berger W (1998) Molecular dissection of Norrie disease. Acta Anat 162:95-100.
2. Berger W, van de Pol D, Warburg M, Gal A, Bleeker-Wagemakers L, de Silva H, Meindl A, Meitinger T, Cremers F, Ropers HH (1992) Mutations in the candidate gene for Norrie disease. Hum Mol Genet 1:461- 465.
3. Berger W, van de Pol D, Bächner D, Oerlemans F, Winkens H, Hameister H, Wieringa B, Hendriks W, Ropers HH (1996) An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Hum Mol Genet 5:51-59.
4. Boulanger A, Liu S, Henningsgaard AA, Yu S, Redmond TM (2000) The upstream region of the Rpe65 gene confers retinal pigment epitheliumspecific expression in vivo and in vitro and contains critical octamer and E-box binding sites. J Biol Chem 275:31274 -31282.
5. Chen J, Connor KM, Aderman CM, Smith LE (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118:526 -533.
6. Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 50:1329 -1335.
7. Connolly SE, Hores TA, Smith LE, D'Amore PA (1988) Characterization of vascular development in the mouse retina. Microvasc Res 36:275-290.
8. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA (2009) Wnt/ beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 106:641- 646.
9. Dorrell MI, FriedlanderM (2006) Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog Retin Eye Res 25:277-295.
10. Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27:552-558.
11. Fruttiger M (2002) Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43:522-527.
12. Fruttiger M (2007) Development of the retinal vasculature. Angiogenesis 10:77- 88.
13. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, YancopoulosGD (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411- 423.
14. Hackett SF, Wiegand S, Yancopoulos G, Campochiaro PA (2002) Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol 192:182-187.
15. Luhmann UF, Meunier D, Shi W, Lüttges A, Pfarrer C, Fundele R, BergerW (2005a) Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis 42:253-262.
16. Luhmann UF, Lin J, Acar N, Lammel S, Feil S, Grimm C, Seeliger MW, Hammes HP, Berger W (2005b) Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci 46:3372-3382.
17. Meindl A, BergerW,Meitinger T, van de Pol D, Achatz H,Dörner C, Haasemann M, Hellebrand H, Gal A, Cremers F (1992) Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet 2:139-143.
18. Meitinger T, Meindl A, Bork P, Rost B, Sander C, Haasemann M, Murken J (1993) Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat Genet 5:376 -380.
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9 -22.
20. Ohlmann A, Scholz M, Goldwich A, Chauhan BK, Hudl K, Ohlmann AV, Zrenner E, Berger W, Cvekl A, Seeliger MW, Tamm ER (2005) Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. J Neurosci 25:1701-1710.
21. Perez-Vilar J, Hill RL (1997) Norrie disease protein (norrin) forms disulfide-linked oligomers associated with the extracellular matrix. J Biol Chem 272:33410 -33415.
22. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92: 905-909.
23. Provis JM (2001) Development of the primate retinal vasculature. Prog Retin Eye Res 20:799-821.
24. Ramsauer M, D'Amore PA (2007) Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J Cell Sci 120:1810 -1817.
25. Rehm HL, Zhang DS, Brown MC, Burgess B, Halpin C, Berger W, Morton CC, Corey DP, Chen ZY (2002) Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J Neurosci 22:4286-4292.
26. Richter M, Gottanka J, May CA, Welge-Lüssen U, Berger W, Lütjen-Drecoll E (1998) Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci 39:2450 -2457.
27. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A 93:4851-4856.
28. Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dubé MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME (2002) Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 32:326 -330.
29. Ruether K, van de Pol D, Jaissle G, Berger W, Tornow RP, Zrenner E (1997) Retinoschisislike alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest Ophthalmol Vis Sci 38:710 -718.
30. Russell AJ, Fincher EF, Millman L, Smith R, Vela V, Waterman EA, Dey CN, Guide S, Weaver VM, Marinkovich MP (2003) Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J Cell Sci 116:3543-3556.
31. Shastry BS, Hejtmancik JF, Trese MT (1997a) Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat 9:396-401.
32. Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT (1997b) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 115:651- 655.
33. Smallwood PM, Williams J, Xu Q, Leahy DJ, Nathans J (2007) Mutational analysis of Norrin-Frizzled4 recognition. J Biol Chem 282:4057- 4068.
34. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
35. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, McMahon AP (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322:1247-1250.
36. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747.
37. Takagi H, Koyama S, Seike H, Oh H, Otani A, Matsumura M, Honda Y (2003) Potential role of the angiopoietin/tie2 system in ischemiainduced retinal neovascularization. Invest Ophthalmol Vis Sci 44:393-402.
38. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, Nathans J (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116:883- 895.
39. Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, Peachey NS, Nathans J (2009) Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139: 285-298.
40. Zorn AM (2001) Wnt signalling: antagonistic Dickkopfs. Curr Biol 11: R592-R595.